Through Crowdberry, you have the opportunity to invest in the Slovak network of private pharmacies, clinics, and polyclinics Váš Lekár, which provides high-quality and affordable healthcare with an emphasis on prevention, modern technologies, and efficiently set processes.

Over the past three months, more than 150 new investors with capital exceeding €1 million have expressed interest in investing. Another milestone achieved by the holding company has also contributed to this.

From Q2 2026, clinical trials of drugs targeting metabolic diseases will be conducted at the Váš Lekár polyclinic in cooperation with an international pharmaceutical company. This step significantly improves the holding's profit profile – it brings a new, high-margin and stable source of income, increases the market value of the group, and strengthens the prestige and attractiveness of the polyclinic for patients and strategic partners.

The webinar will also give you an exclusive professional and personal insight from Dr. Boris Bajer – a doctor, co-owner of Váš Lekár and a well-known public figure who has long been shaping the debate on modern, preventive and data-driven healthcare in Slovakia.

What did you learn during the webinar?

• strategic and personal update, including the conclusion of a partnership for clinical trials and a new and stable source of income
• overview of the investment opportunity, its expected appreciation, whether in the form of an exit or dividend payment
• financial outlook and company growth
• investor protection in the form of liquidity preference and the current status of the investor club without dilution of shares

The webinar was led by partners Michal Nešpor, Dano Gašpar, Peter Potúček, CEO of Váš Lekár and Mudr. Boris Bajer.